|View printer-friendly version|
|October 29, 2010 3:59 p.m.|
|Teva Invites Public to Listen to Its Respiratory Opportunity Webcast|
|Jersualem, October 29, 2010 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast of its Respiratory Opportunity Meeting on Thursday, November 4, 2010 at 10:00 a.m. ET.|
What: Teva's Respiratory Opportunity Meeting
Who: Teva Management
When: Thursday, November 4, 2010 at 10:00 a.m. ET
How: Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,250 molecules and a direct presence in approximately 60 countries. Teva's branded businesses focus on neurological, respiratory and women's health therapeutic areas as well as biologics. Teva's leading innovative product, Copaxone®, is the number one prescribed treatment for multiple sclerosis. Teva employs more than 40,000 people around the world and reached $13.9 billion in net sales in 2009.